Skip to main content
PVLA logo
PVLA
(NASDAQ)
Palvella Therapeutics, Inc.
$156.13-- (--)
Loading... - Market loading

Palvella Therapeutics (PVLA) Stock Price & Financial Analysis

Palvella Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$154.35 - $160.33
52-Week High$161.38
52-Week Low$40.22
Open$156.55
Volume109.81K
Average Volume (3M)207.59K
Market Cap1.76B
Shares Outstanding11.25M
Price to Book (P/B)63.44
EV/EBITDA-34.64
50-Day MA$133.97
200-Day MA$111.81
52-Week Change285.75%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Palvella Therapeutics

What is the current stock price for PVLA?

As of the latest trading session, PVLA stock trades at $156.13. The 52-week range is $40.22–$161.38, with a day range of $154.35–$160.33.

What is the P/E ratio for PVLA?

The P/E ratio (Price-to-Earnings) for PVLA is shown in the Key Statistics section. This valuation metric helps compare Palvella Therapeutics, Inc. to industry peers.

Does PVLA pay dividends?

Palvella Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PVLA?

Based on 8 analysts, the consensus for PVLA is Buy.

What is the market cap of PVLA?

Palvella Therapeutics's market capitalization is $1.76B, classifying it as a small-cap company. Palvella Therapeutics operates in the Healthcare sector within the Biotechnology industry.